Clear Search sequence regions


  • cathelicidins (2)
  • chronic skin disease (1)
  • CXCL2 (1)
  • humans (1)
  • IL 1β (1)
  • IL 6 (1)
  • LL37 (3)
  • mice (1)
  • neutrophils (9)
  • patients (1)
  • pcr (2)
  • peptides (2)
  • protein human (1)
  • repress (1)
  • ROS (1)
  • rosacea (10)
  • signal (1)
  • skin erythema (1)
  • TLR2 (11)
  • tlr2 protein human (1)
  • Sizes of these terms reflect their relevance to your search.

    Rosacea is a chronic facial inflammatory skin disease that occurs with dysfunction of the immune system. Colchicine was reported to have anti-inflammatory properties. However, the impact of colchicine on rosacea remains unclear. In the present study, the phenotype of rosacea lesions was evaluated by the redness score, inflammatory biomarkers were analyzed by reverse transcription PCR (RT‒PCR), and the infiltration of inflammatory cells was assessed by IHC analysis and immunofluorescence in a rosacea-like mouse model. In vitro, RT‒PCR was used to identify the inflammatory factors that Toll-like receptor 2 (TLR2) agonist caused neutrophils to produce, and immunofluorescence and coimmunoprecipitation were used to identify putative signalling pathways. We found that skin erythema and histopathological alterations, as well as elevated proinflammatory factors (IL-1β, IL-6, TNFα, CXCL2) and CAMP, were significantly ameliorated by colchicine treatment in LL37-induced rosacea-like mice. In addition, colchicine reduced the colocalization of TLR2 and neutrophils and the formation of neutrophil extracellular trap networks (NET) in mouse lesions. In neutrophils, colchicine markedly reduced TLR2 agonist-induced inflammatory biomarker expression, NET formation, and ROS production. Moreover, we found that LL37 could bind to TLR2 upon activation of TLR2 in neutrophils. Importantly, colchicine could repress the combination of TLR2 and LL37 in vivo. Finally, bioinformatics methods further validated the key molecules of neutrophil-related inflammation in rosacea, which is consistent with our experimental findings. Collectively, colchicine ameliorated rosacea-like dermatitis by regulating the neutrophil immune response activated by the TLR2 pathway, indicating that it could be an effective therapeutic option for patients with rosacea. © 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

    Citation

    Xin Yuan, Liang Sheng, Guang Shi, Leiwei Jiang, Chengxiang Lian. Colchicine Alleviates Rosacea by Inhibiting Neutrophil Inflammation Activated by the TLR2 Pathway. Inflammation. 2024 Jun;47(3):1002-1014

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38279067

    View Full Text